Niagen Bioscience, Inc. (NAGE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.18
• Market Cap: $425.37M
• P/E Ratio: 22.21
• EPS: $0.24
• 52-Week High: $14.69
• 52-Week Low: $4.74

Market Sentiment

Niagen Bioscience, Inc. currently has a Bullish sentiment score of 0.36.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. is an innovative bioscience firm based in Los Angeles, California, focused on advancing healthy aging and improving quality of life through cutting-edge research in cellular health and metabolic science. The company develops and markets products aimed at promoting vitality and longevity, capitalizing on the increasing global emphasis on health and wellness. With its strong commitment to scientific excellence and a growing portfolio of pioneering solutions, Niagen is st...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Niagen Bioscience, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NAGE pay dividends?

Niagen Bioscience, Inc. (NAGE) does not currently pay a regular dividend.

What is NAGE's P/E ratio?

Niagen Bioscience, Inc. has a price-to-earnings (P/E) ratio of 22.21.

What is NAGE's market cap?

Niagen Bioscience, Inc. (NAGE) has a market capitalization of $425.37M with a current stock price of $5.18.